<DOC>
	<DOCNO>NCT02025036</DOCNO>
	<brief_summary>A three-arm Phase III trial start Oct. 2014 . Definitive chemoradiotherapy cisplatin plus 5-fluorouracil standard Western country esophagus cancer . But China toxic reaction , patient stop halfway . Because low toxicity , chemotherapy regimen capecitabine without oxaliplatin widely use clinical . The purpose study confirm difference Capecitabine plus without oxaliplatin cisplatin plus 5-fluorouracil definitive chemoradiotherapy esophagus squamous cell carcinoma . A total 630 patient accrue China within 2 year . The primary endpoint overall survival secondary endpoint include progression-free survival , response rate , pathologic complete response rate adverse event .</brief_summary>
	<brief_title>Chemoradiotherapy Capecitabine With Without Oxaliplatin Versus Cisplatin-5-FU Esophageal Squamous Cancer</brief_title>
	<detailed_description>We plan recruit patient pathologically confirm esophageal squamous cell carcinoma Oct 2014 . The patient divide three groups.Experimental group 1 : single drug Capecitabine concurrent radiotherapy.Experimental group 2 : Capecitabine plus oxaliplatin concurrent radiotherapy . Control group : cisplatin plus 5-fluorouracil concurrent radiotherapy . To evaluate overall survival three group . Also observe patient 's progression-free survival , response rate , pathologic complete response rate adverse event .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>age 1875years old Histologically proven squamous cell carcinoma esophagus tumor T24N02M0 The patient receive surgery chemoradiotherapy . Hb≥80g/L , absolute neutrophil count ≥1.5×109/L , Plt≥90×109/L , ALT、AST≤2.5*N , Cr≤1.5*N. performance status score 02 pregnant , lactate woman Oxaliplatin fluorouracil Allergy metabolic disorder Radiotherapy contraindication History organ transplantation Brain metastasis The peripheral nervous system disorder Severe infection Oral capecitabine difficulty , dysphagia , The activity digestive ulcer , Gastrointestinal bleeding Severe chronic disease , , hepatopathy , nephropathy , respiratory disease , high blood pressure , diabetes . Other malignant tumor recent 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Chemoradiotherapy， Esophageal Squamous Cancer</keyword>
</DOC>